A phase III trial to combine the effects of a group of medications with another combination in patients with newly diagnosed Symptomatic Multiple Myeloma
Cancer - Leukemia,
Syed Ali, MD
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
The purpose of this study is to compare the effects, good and/or bad, of a combination of carfilzomib, lenalidomide and dexamethasone with another combination of bortezomib, lenalidomide and dexamethasone.
Newly diagnosed multiple myeloma